openPR Logo
Press release

Osteopenia Treatment By Key Players Overview ( Bayer, Primus Pharmaceuticals, Inc., Eurotec Medical Systems s.r.l., GE Healthcare, Hologic Inc., Osteosys Corp., Swissray, DMS Imaging, Medonica Co. Ltd., Demetech AB and others.)

01-22-2019 08:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Osteopenia Treatment By Key Players Overview ( Bayer, Primus

Osteopenia Treatment Market: Overview

Thinning of bone mass is known as Osteopenia. Osteopenia is considered to be a serious risk factor for osteoporosis. Osteopenia is commonly observed in people aged above 50 who do not have osteoporosis but have average bone density. Smoking and drinking can affect the calcium level in the body, leading to weakening of bones. High salt, caffeine and soda consumption can also lead to osteopenia. Osteopenia treatment is a must for people above the age of 50. Healthy lifestyle plays a very important role in strengthening of bones. Regular exercise and healthy diet improve bone density. Developing healthy habits and osteopenia treatment methods can slow osteopenia and strengthen bones and prevent osteoporosis. Osteopenia treatment includes medications, which include bisphosphonate medications, such as ibandronate (Boniva), alendronate (Fosamax), risedronate (Actonel), zoledronate (Reclast) and raloxifene (Evista). Calcium and vitamin D supplements are also a part of osteopenia treatment. According to the National Osteoporosis Foundation, women aged 65 years and above & men aged 70 years and above should be tested for osteopenia. Also, adults aged 50 and above with a fractured bone, postmenopausal women, adults taking medication, such as prednisone or other steroids, and prone to medical conditions associated with bone loss, such as rheumatoid arthritis, should be tested for osteopenia. These group of people are at a high risk of developing osteopenia and osteoporosis. All these factors will act as driving factors for the growth of the osteopenia treatment market. 

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2579

Osteopenia Treatment Market: Drivers and Restraints

The growing aging population is one of the key factors responsible for the growth of osteopenia treatment market. Aging population is always at a high risk of osteopenia as aging causes loss of bone density. Moreover, increasing alcohol consumption is another factor that will drive the growth of the osteopenia treatment market. However, lack of awareness about osteopenia treatment may restraint the growth of the market. Additionally, the high cost of treatment and unavailability of treatments options in developing countries will also hamper the growth of the osteopenia treatment market.

Osteopenia Treatment Market: Overview

The global market for osteopenia treatment is expected to witness high growth during the forecast period. Increasing the patient pool and unhealthy diet and lifestyle choices are responsible for boosting the osteopenia treatment market. However, the growth of the osteopenia treatment market will be limited by several side-effects caused by calcium and vitamin D supplements, such as muscle weakness, bone pain, lack of energy, etc. Additionally, lack of knowledge regarding osteopenia treatment is another factor further expected to hamper the growth of osteopenia treatment market during the forecast period.

Osteopenia Treatment Market: Regional Outlook

Geographically, the global osteopenia treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America, followed by Europe, is expected to be the leading market in the global osteopenia treatment market owing to the advanced healthcare spending and infrastructure and increasing treatment coverage by Medicare and Medicaid in the US. The Osteopenia treatment market in Asia Pacific excluding Japan is expected to show significant CAGR growth due to increasing patient pool due to the growing aging population.

Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2579

Osteopenia Treatment Market: Key Players

The global osteopenia treatment market is highly fragmented. Examples of some of the key players operating in the global osteopenia treatment market are Bayer, Primus Pharmaceuticals, Inc., Eurotec Medical Systems s.r.l., GE Healthcare, Hologic Inc., Osteosys Corp., Swissray, DMS Imaging, Medonica Co. Ltd., Demetech AB and others.

For more information on this report, please visit:https://www.factmr.com/report/2579/osteopenia-treatment-market

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteopenia Treatment By Key Players Overview ( Bayer, Primus Pharmaceuticals, Inc., Eurotec Medical Systems s.r.l., GE Healthcare, Hologic Inc., Osteosys Corp., Swissray, DMS Imaging, Medonica Co. Ltd., Demetech AB and others.) here

News-ID: 1519980 • Views:

More Releases from Fact.MR

Global Data Catalog Market to Explode to $12.3 Billion by 2035, Driven by AI and Data Governance Mandates
Global Data Catalog Market to Explode to $12.3 Billion by 2035, Driven by AI and …
The global Data Catalog Market is undergoing a rapid, technology-driven transformation, shifting its role from a passive metadata repository to an intelligent, active data intelligence platform. Propelled by the exponential growth in complex data and regulatory demands, the market is projected to reach an estimated US$12.32 Billion by 2035, according to leading market analysis. This dramatic surge represents a Compound Annual Growth Rate (CAGR) of 21.9% throughout the forecast period of
Content Delivery Network (CDN) Market to Reach USD 45.2 Billion by 2035 | Akamai Technologies, Tata Communications, Microsoft Corporation, Alibaba Cloud, IBM Corporation, StackPath, Limelight Networks
Content Delivery Network (CDN) Market to Reach USD 45.2 Billion by 2035 | Akamai …
The latest report on the Content Delivery Network (CDN) Market, forecasting robust growth propelled by surging global data traffic, the proliferation of streaming services, and the escalating demand for low-latency digital experiences. Valued at USD 18.5 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 9.4%, reaching USD 45.2 billion by 2035. This trajectory reflects the indispensable role of CDNs in
Energy-based Aesthetic Devices Market Grow at a 10.8% CAGR by 2035 | Key Players: Cynosure, Lumenis Ltd., Alma Lasers Inc., Allergan Plc, Cutera, Merz Pharma GmbH & Co. KGaA
09-30-2025 | Health & Medicine
Fact.MR
Energy-based Aesthetic Devices Market Grow at a 10.8% CAGR by 2035 | Key Players …
latest report on the Energy-based Aesthetic Devices Market, forecasting robust growth propelled by surging demand for non-invasive dermatological treatments, technological innovations in laser, radiofrequency, ultrasound, and light-based systems, and heightened beauty awareness among consumers. Valued at USD 5,476.2 million in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 10.8%, reaching USD 15,180.4 million by 2035. This trajectory reflects the market's pivotal role
Global Surgical Tourniquets Market Projected to Nearly Triple, Reaching US$1.59 Billion by 2035
09-30-2025 | Health & Medicine
Fact.MR
Global Surgical Tourniquets Market Projected to Nearly Triple, Reaching US$1.59 …
The global surgical tourniquets market is poised for significant expansion over the next decade, driven by a global surge in orthopedic surgeries, heightened demand for safer intraoperative blood control, and major technological advancements in pressure regulation systems. According to a comprehensive analysis by Fact.MR, the market, valued at US 670 millionin 2025,is forecasted to grow at a steady Compound Annual Growth Rate(CAGR) of 91.59 billion. This robust growth trajectory is

All 5 Releases


More Releases for Osteopenia

Osteopenia Treatment Market: Size, Shares, Trends, Growth to Reach USD 21.57 Bil …
Osteopenia Treatment Market Size Was Valued at USD 14.77 Billion in 2023, and is Projected to Reach USD 21.57 Billion by 2032, Growing at a CAGR of 4.30% From 2024-2032. The Osteopenia Treatment Market makes a speciality of medical answers designed to manipulate and improve bone density in people diagnosed with osteopenia, a condition characterised through decrease-than-normal bone mineral density (BMD). Although not as severe as osteoporosis, osteopenia increases the threat
Osteopenia Treatment Market Overview, Segmentation, And Growth Strategies
Osteopenia Treatment Market report inspects the market with respect to general market conditions, market improvement, market scenarios, development, cost and profit of the specified market regions, position and comparative pricing between major players. This market report is structured with the thorough market analysis carried out by a team of industry experts, dynamic analysts, skilful forecasters and well-informed researchers. Key players in the market, major collaborations, merger and acquisitions along with
Osteopenia Treatment Market is Grabbing New opportunities by Top Key Players - B …
The global Osteopenia Treatment market size is projected to reach US$ 16.3 Billion by 2027, at a CAGR of 4.9% during 2021-2027. The developing maturing populace is one of the key variables liable for the development of osteopenia treatment market. Maturing populace is consistently at a high danger of osteopenia as maturing causes deficiency of bone thickness. Also, expanding liquor utilization is another component that will drive the development of
Bone and Mineral Disorders Market Is Expected To Grow At A Rapid Pace Throughout …
Acumen Research and Consulting has announced the addition of the "Bone and Mineral Disorders Market” report to their offering. The Bone and Mineral Disorders Market Report 2018 is an in depth study analyzing the current state of the Bone and Mineral Disorders Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Bone and Mineral Disorders Market provides analysis
Global Osteopenia Treatment Market Assessment and Key Insights Analyzed till 202 …
The growing aging population is one of the key factors responsible for the growth of osteopenia treatment market. Aging population is always at a high risk of osteopenia as aging causes loss of bone density. Moreover, increasing alcohol consumption is another factor that will drive the growth of the Osteopenia Treatment Market. However, lack of awareness about osteopenia treatment may restraint the growth of the market. Additionally, the high cost
Osteopenia Treatment Market Estimated to Record Highest CAGR by 2018 to 2026
Thinning of bone mass is known as Osteopenia. Osteopenia is considered to be a serious risk factor for osteoporosis. Osteopenia is commonly observed in people aged above 50 who do not have osteoporosis but have average bone density. Smoking and drinking can affect the calcium level in the body, leading to weakening of bones. High salt, caffeine and soda consumption can also lead to osteopenia. Osteopenia treatment is a must